Chronic kidney disease (CKD) is a long-term condition in which the kidneys do not work
correctly. It has a high prevalence and represents a serious hazard to human health and …

Transforming growth factor beta (TGF-β) has been recognized as an important mediator in
the genesis of chronic kidney diseases (CKD), which are characterized by the accumulation …

Aims/hypothesis Glucagon-like peptide-1 receptor agonists (GLP-1ras) and sodium–glucose
cotransporter 2 inhibitors (SGLT2is) have shown kidney-protective effects. Improved kidney …

Chronic kidney disease (CKD) comprises a group of pathologies in which the renal
excretory function is chronically compromised. Most, but not all, forms of CKD are …

Chronic kidney disease (CKD) is associated with high mortality rates and heavy economic
and social burdens. Nearly 10% of the United States population suffer from CKD, with fatal …

Fibrosis is a hallmark of progressive kidney diseases. The overexpression of profibrotic
cytokine, namely transforming growth factor β (TGF-β) due to excessive inflammation and …

Aims Doxorubicin is a prominent anticancer agent. However, its organotoxic potential has
restricted its clinical use. The current study was performed to investigate the protective effect …

Fibrosis is the unrelenting deposition of excessively large amounts of insoluble interstitial
collagen due to profound matrigenic activities of wound-associated myofibroblasts during …

Nanomedicine technology is a rapidly developing field of research and application that uses
nanoparticles as a platform to facilitate the diagnosis and treatment of diseases …

Aims Limited data regarding the association between remnant cholesterol (RC) and chronic
kidney disease (CKD), largely based on an estimated glomerular filtration rate (eGFR) of< …